Exhibit 1090

Cochrane ousted researcher over improper use of letterhead, co-chair says

Exhibit 1090 · News report quoting a board co-chair

Cochrane ousted researcher over improper use of letterhead, co-chair says

Gøtzsche was “baselessly undermining Cochrane’s credibility and independence,” Koster said Thursday.

Reports that Cochrane's governing board co-chair Marguerite Koster said the board's expulsion of Peter Gøtzsche rested on his use of Cochrane Nordic letterhead for personal views, including in a homicide trial, and repeated conduct that she described as baselessly undermining Cochrane's credibility; four board members resigned after the first vote.

Source: STAT (with Retraction Watch)
Date: 28 September 2018
Quoted from: Paragraph after the 'Related' box
Grade: Reported
Document: https://www.statnews.com/2018/09/28/cochrane-ousted-researcher-over-letterhead-use/
Accessed: 2026-11-10
Cited by: Findings citing this exhibit
Note: Grade reported. The Board's own statement is exhibit cochrane-2018-governing-board-gotzsche-statement (exhibit 944).

Cited by

Finding INF-5.14: Primary record Cochrane's Governing Board voted unanimously on 25 September 2018 to end Peter Gøtzsche's membership, his Board seat and his directorship of the Nordic Cochrane Centre, citing a pattern of disruptive behavior, personal views presented as Cochrane's, and breaches of trustee confidentiality. Cochrane's editor in chief had written on 29 August 2018 that the BMJ Evidence-Based Medicine article by Gøtzsche and a coauthor on Cochrane's HPV vaccine review "substantially overstated its criticisms."